文献速递肥胖与代谢综合征糖尿病

代谢综合征受试者脂肪组织来源间充质干细胞的成脂功能受损:FGF2可能的保护作用

Adipogenic Impairment of Adipose Tissue-Derived Mesenchymal Stem Cells in Subjects With Metabolic Syndrome: Possible Protective Role of FGF2.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

本研究为期2年,纳入20例接受减重手术的病态肥胖患者与40例接受胆囊切除术的受试者,比较不同代谢状态下脂肪组织来源间充质干细胞(ASCs)的成脂、纤维化基因表达、增殖、克隆潜能及凋亡易感性。结果显示代谢状况恶化伴随成脂基因表达、增殖率、克隆潜能及FGF2外露减少,且两组间凋亡易感性与Smad7表达存在差异;作者认为这些变化可能参与脂肪组织扩张的调控。

要点

  • 代谢状况恶化伴随ASCs成脂基因mRNA、增殖率与克隆潜能下降。
  • 代谢综合征患者ASCs的FGF2向细胞表面外露减少。
  • 两组间ASCs凋亡易感性与Smad7表达存在差异。

核心结论

  • 作者认为,成脂基因mRNA与克隆潜能下降及纤维化蛋白随代谢改变而积累,可能是控制新生脂肪细胞数量与大小并参与脂肪组织扩张障碍的相关机制。

研究设计与样本

  • 为期2年的研究,纳入接受减重手术的病态肥胖患者20例与接受胆囊切除术的受试者40例,设置于大学医院。
  • ASCs取自内脏与皮下脂肪组织,采用定量聚合酶链反应检测成脂与纤维化基因表达,分别以蛋白质印迹与酶联免疫吸附试验检测Smad7与成纤维细胞生长因子2。
  • 评估ASCs的凋亡易感性、群体倍增时间与克隆潜能。

主要发现

  • 患者代谢状况恶化伴随两种组织来源ASCs的内在成脂基因表达水平下降、增殖率降低、克隆潜能降低及FGF2向细胞表面外露减少。
  • 无代谢综合征患者的ASCs在凋亡易感性与TGFβ信号抑制蛋白Smad7表达方面与代谢综合征患者的ASCs存在差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The decreased expansion capacity of adipose tissue plays a crucial role in the onset of disorders associated with metabolic syndrome. OBJECTIVE: The aim of this study was to examine the state of adipose tissue-derived mesenchymal stem cells (ASCs) from obese subjects with different metabolic profiles. DESIGN: This was a 2-year study to enroll subjects who underwent bariatric surgery or cholecystectomy. SETTING: University Hospital. PATIENTS AND INTERVENTION: Patients who underwent either bariatric surgery (20 morbidly obese) or cholecystectomy (40 subjects) participated in the study. MAIN OUTCOME MEASURES: ASCs were obtained from both visceral and subcutaneous adipose tissue. Adipogenic, fibrotic gene expression was quantified by quantitative polymerase chain reaction; Smad7 and fibroblast growth factor 2 were quantified by western blotting and enzyme-linked immunosorbent assay, respectively. The susceptibility of ASCs to apoptosis, their population doubling time, and their clonogenic potential were evaluated. RESULTS: The worsening metabolic profile of the patients was accompanied by a decrease in the intrinsic levels of adipogenic gene expression, reduced proliferation rate, clonogenic potential, and exportation of fibroblast growth factor 2 to the cell surface of the ASCs derived from both tissues. In addition, the ASCs from patients without metabolic syndrome showed differences in susceptibility to apoptosis and expression of TGFβ-signaling inhibitory protein Smad7 with respect to the ASCs from patients with metabolic syndrome. CONCLUSION: Our results suggest that the decrease in adipogenic-gene mRNA and clonogenic potential, as well as the accumulation of fibrotic proteins with metabolic alterations, could be a relevant mechanism controlling the number and size of neogenerated adipocytes and involved in alteration of adipose-tissue expansion.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Oliva-Olivera W, Coín-Aragüez L, Lhamyani S, et al. Adipogenic Impairment of Adipose Tissue-Derived Mesenchymal Stem Cells in Subjects With Metabolic Syndrome: Possible Protective Role of FGF2. J Clin Endocrinol Metab. 2017. PMID: 27967316. doi:10.1210/jc.2016-2256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。